BioCentury
ARTICLE | Company News

Opalia Pharma S.A., Recordati deal

July 29, 2013 7:00 AM UTC

Recordati said it acquired 90% of branded generics company Opalia in a deal valued at about €37 million ($48.6 million). Recordati estimates Opalia will have about €18.5 million ($24.3 million) in 201...